These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 11836161)

  • 1. Heterozygosity of CDAN II (HEMPAS) gene may be detected by the analysis of erythrocyte membrane glycoconjugates from healthy carriers.
    Zdebska E; Mendek-Czajkowska E; Ploski R; Woêniewicz B; Koscielak J
    Haematologica; 2002 Feb; 87(2):126-30. PubMed ID: 11836161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoconjugate abnormalities in patients with congenital dyserythropoietic anaemia type I, II and III.
    Zdebska E; Gołaszewska E; Fabijańska-Mitek J; Schachter H; Shalev H; Tamary H; Sandström H; Wahlin A; Kościelak J
    Br J Haematol; 2001 Sep; 114(4):907-13. PubMed ID: 11564084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycophorin A in two patients with congenital dyserythropoietic anemia type I and type II is partly unglycosylated.
    Zdebska E; Adamczyk-Popławska M; Kościelak J
    Acta Biochim Pol; 2000; 47(3):773-9. PubMed ID: 11310976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short report: erythrocyte membranes from a patient with congenital dyserythropoietic anaemia type I (CDA-I) show identical, although less pronounced, glycoconjugate abnormalities to those from patients with CDA-II (HEMPAS).
    Zdebska E; Woźniewicz B; Adamowicz-Salach A; Kościelak J
    Br J Haematol; 2000 Sep; 110(4):998-1001. PubMed ID: 11054095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Band 3 glycoprotein and glycophorin A from erythrocytes of children with congenital disorder of glycosylation type-Ia are underglycosylated.
    Zdebska E; Musielak M; Jaeken J; Kościelak J
    Proteomics; 2001 Feb; 1(2):269-74. PubMed ID: 11680873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities of erythrocyte glycoconjugates are identical in two families with congenital dyserythropoietic anemia type II with different chromosomal localizations of the disease gene.
    Zdebska E; Iolascon A; Spychalska J; Perrotta S; Lanzara C; Smolenska-Sym G; Koscielak J
    Haematologica; 2007 Mar; 92(3):427-8. PubMed ID: 17339199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital dyserythropoietic anaemia type II (HEMPAS) and its molecular basis.
    Fukuda MN
    Baillieres Clin Haematol; 1993 Jun; 6(2):493-511. PubMed ID: 8043936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and genetics of congenital dyserythropoietic anemias (CDA)].
    Rössler J; Havers W
    Klin Padiatr; 2000; 212(4):153-8. PubMed ID: 10994542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the N-glycosylation phenotype of erythrocyte membrane proteins in congenital dyserythropoietic anemia type II (CDA II/HEMPAS).
    Denecke J; Kranz C; Nimtz M; Conradt HS; Brune T; Heimpel H; Marquardt T
    Glycoconj J; 2008 May; 25(4):375-82. PubMed ID: 18166993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HEMPAS disease: genetic defect of glycosylation.
    Fukuda MN
    Glycobiology; 1990 Sep; 1(1):9-15. PubMed ID: 2136385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital dyserythropoietic anemia type II: serologic and morphologic family study.
    Ricci P; Baccarani M; Biagini G; Preda P; Tomasini I; Zucchelli P; Tura S
    Nouv Rev Fr Hematol (1978); 1979; 21(2):197-207. PubMed ID: 514807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective glycosylation of erythrocyte membrane glycoconjugates in a variant of congenital dyserythropoietic anemia type II: association of low level of membrane-bound form of galactosyltransferase.
    Fukuda MN; Masri KA; Dell A; Thonar EJ; Klier G; Lowenthal RM
    Blood; 1989 Apr; 73(5):1331-9. PubMed ID: 2495036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital dyserythropoietic anemia type II: molecular basis and clinical aspects.
    Iolascon A; D'Agostaro G; Perrotta S; Izzo P; Tavano R; Miraglia del Giudice B
    Haematologica; 1996; 81(6):543-59. PubMed ID: 9009444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional consequences of an N-glycosylation mutation (HEMPAS) affecting human erythrocyte membrane glycoproteins.
    Kameh H; Landolt-Marticorena C; Charuk JH; Schachter H; Reithmeier RA
    Biochem Cell Biol; 1998; 76(5):823-35. PubMed ID: 10353717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polylactosamines are not obligate receptors for invasion of Plasmodium falciparum malaria as shown in HEMPAS variant II-gal- erythrocytes.
    Dhume ST; Adams-Burton CR; Shumak KH; Laine RA
    Glycobiology; 1994 Dec; 4(6):903-8. PubMed ID: 7734852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in erythrocyte membrane protein in congenital dyserythropoietic anemia type II (C.D.A.II, HEMPAS)].
    Scartezzini P; Forni GL; Baldi M; Veneziano G; Baffico M
    Pathologica; 1985; 77(1052):631-8. PubMed ID: 3916299
    [No Abstract]   [Full Text] [Related]  

  • 17. HEMPAS. Hereditary erythroblastic multinuclearity with positive acidified serum lysis test.
    Fukuda MN
    Biochim Biophys Acta; 1999 Oct; 1455(2-3):231-9. PubMed ID: 10571015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Abnormalities of the erythrocyte membrane ultrastructure and the membrane proteins in a patient with HEMPAS, alpha thalassemia and complicated diabetes].
    Li JY; Xu YQ; Huang ZX; Zhou H; Wan SD
    Zhonghua Nei Ke Za Zhi; 2004 Jun; 43(6):426-8. PubMed ID: 15312436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary defect of congenital dyserythropoietic anemia type II. Failure in glycosylation of erythrocyte lactosaminoglycan proteins caused by lowered N-acetylglucosaminyltransferase II.
    Fukuda MN; Dell A; Scartezzini P
    J Biol Chem; 1987 May; 262(15):7195-206. PubMed ID: 2953718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anomalous clustering of underglycosylated band 3 in erythrocytes and their precursor cells in congenital dyserythropoietic anemia type II.
    Fukuda MN; Klier G; Yu J; Scartezzini P
    Blood; 1986 Aug; 68(2):521-9. PubMed ID: 3730615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.